Skip Navigation

Poor quality malaria drugs: how many and where? (Research brief)

Research brief

Category: Intervention Manuals

Sub Category: Intervention Manuals

Author: ACT Consortium Drug Quality Project Team

Published Date: 25 May 2015


[Français / Português]

The Artemisinin-based Combination Therapy (ACT) Consortium Drug Quality programme collected and analysed the quality of over 10,000 artemisinin-based drugs from six malaria endemic countries: Cambodia, Equatorial Guinea, Ghana, Nigeria, Rwanda and Tanzania.

Previous reports had suggested that up to one third of antimalarials were “fake”. The Drug Quality programme showed that falsified antimalarials are not as common as previously reported. However, substandard drugs are present in all countries studied and monotherapy tablets are still available in some places.


Research Aims

Related Projects

< Back